Home › Therapeutic areas › Oncology › Mesothelioma

Mesothelioma (3 companies)

Companies with an active program in Mesothelioma.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
CMPX Compass Therapeutics Oncology 1 Phase 2 $109M 15
NVCT Nuvectis Pharma HematologyOncology+1 Rare 1 Phase 3 $660M 9
SLS SELLAS Life Sciences Group Oncology 1 Phase 3 $3.90B 9